Technical Analysis for SNN - Smith & Nephew SNATS, Inc.

Grade Last Price % Change Price Change
F 38.53 1.29% 0.49
SNN closed up 1.29 percent on Friday, March 5, 2021, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical SNN trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Oversold Stochastic Weakness 0.00%
Oversold Stochastic Weakness 1.29%
Stochastic Buy Signal Bullish 0.60%
Gapped Down Weakness 0.60%
Oversold Stochastic Weakness 0.60%
Outside Day Range Expansion -1.96%
Oversold Stochastic Weakness -1.96%
Narrow Range Bar Range Contraction -1.48%
Inside Day Range Contraction -1.48%
Older End-of-Day Signals for SNN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Smith & Nephew SNATS, Inc. Description

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company's Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and orthopaedic trauma fixation products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, such as cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company's Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. The company's principal products include ALLEVYN and DURAFIBER branded wound care products; ACTICOAT branded products for infection management; and negative pressure wound therapy products. Smith & Nephew plc primarily serves medical and surgical service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Surgery Bone Camera Healthcare Providers Infection Medical Devices Wound Knee Ulcer Visualization Orthopedic Surgery Burns Implant Medical Device Deformity Minimally Invasive Procedures Fluid Management Sports Medicine The Joint First Aid Surgical Specialties Invasive Surgery Minimally Invasive Surgery Medicine Products Arthroscopy Wound Care Products Bone Cement Chronic Wound Chronic Wounds Closure Products Negative Pressure Wound Therapy Surgical Devices Venous Leg Ulcers Wound Bed Preparation

Is SNN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 46.1
52 Week Low 26.07
Average Volume 371,438
200-Day Moving Average 40.63
50-Day Moving Average 42.55
20-Day Moving Average 41.20
10-Day Moving Average 39.32
Average True Range 0.98
ADX 25.45
+DI 15.02
-DI 39.35
Chandelier Exit (Long, 3 ATRs ) 41.90
Chandelier Exit (Short, 3 ATRs ) 40.45
Upper Bollinger Band 45.40
Lower Bollinger Band 37.00
Percent B (%b) 0.18
BandWidth 20.38
MACD Line -1.27
MACD Signal Line -0.92
MACD Histogram -0.3449
Fundamentals Value
Market Cap 16.89 Billion
Num Shares 438 Million
EPS 0.89
Price-to-Earnings (P/E) Ratio 43.20
Price-to-Sales 3.64
Price-to-Book 3.44
PEG Ratio 2.37
Dividend 0.58
Dividend Yield 1.51%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.88
Resistance 3 (R3) 39.73 39.13 39.65
Resistance 2 (R2) 39.13 38.79 39.20 39.58
Resistance 1 (R1) 38.83 38.57 38.98 38.98 39.50
Pivot Point 38.23 38.23 38.31 38.31 38.23
Support 1 (S1) 37.93 37.89 38.08 38.08 37.56
Support 2 (S2) 37.33 37.68 37.41 37.48
Support 3 (S3) 37.03 37.33 37.41
Support 4 (S4) 37.18